ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,615,595 | +932.0% | 501,680 | +1270.1% | 0.08% | +1014.3% |
| Q2 2023 | $1,319,310 | 0.0% | 36,617 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,319,310 | -6.3% | 36,617 | +2.7% | 0.01% | -12.5% |
| Q4 2022 | $1,408,729 | +16.0% | 35,646 | +17.9% | 0.01% | 0.0% |
| Q3 2022 | $1,214,000 | +75.7% | 30,236 | +70.2% | 0.01% | +166.7% |
| Q1 2022 | $691,000 | -9.3% | 17,761 | -15.9% | 0.00% | -25.0% |
| Q3 2021 | $762,000 | -16.8% | 21,108 | -5.6% | 0.00% | -20.0% |
| Q2 2021 | $916,000 | -29.7% | 22,366 | -25.1% | 0.01% | -28.6% |
| Q1 2021 | $1,303,000 | +16.4% | 29,878 | +33.6% | 0.01% | +16.7% |
| Q4 2020 | $1,119,000 | – | 22,360 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |